PMID: 42136641

Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective.

Horenstein Alberto L, Frerichs Kristine A, Faini Angelo C, van de Donk Niels W C J, Malavasi Fabio

Frontiers in immunology · 2026

Vol. 17, pp. 1769281

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansMultiple MyelomaADP-ribosyl Cyclase 1Antibodies, MonoclonalImmunotherapyCell Line, TumorAdenosineNADMembrane GlycoproteinsAntibodies, Monoclonal, Humanized

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.